Mission F1 Oncology’s mission is to provide lasting remissions via cellular therapies for patients with no other options.
We are driven to achieve clinically relevant reductions in cancer mortality through industrial innovation and scientific integrity, while generating accessible solutions for patients around the world.
Description F1 Oncology is a clinical-stage biotechnology company committed to bringing to market CAR-T therapies for the treatment of cancer. Founded in 2015, The company has rapidly built its core technologies and a growing global presence with operations in China (Shanghai and Shenzhen), Grand Cayman, and across the US with sites in West Palm Beach and San Diego.